000 01457 a2200409 4500
005 20250515080835.0
264 0 _c20080807
008 200808s 0 0 eng d
022 _a0272-4340
024 7 _a10.1007/s10571-007-9165-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHe, Zhi
245 0 0 _aPiracetam improves cognitive deficits caused by chronic cerebral hypoperfusion in rats.
_h[electronic resource]
260 _bCellular and molecular neurobiology
_cJun 2008
300 _a613-27 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCognition Disorders
_xdrug therapy
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aElectrophysiology
650 0 4 _aHypoxia-Ischemia, Brain
_xcomplications
650 0 4 _aMale
650 0 4 _aMaze Learning
_xdrug effects
650 0 4 _aNeuroprotective Agents
_xtherapeutic use
650 0 4 _aPiracetam
_xtherapeutic use
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSwimming
650 0 4 _aTumor Suppressor Protein p53
_xmetabolism
650 0 4 _abcl-2-Associated X Protein
_xmetabolism
700 1 _aLiao, Yun
700 1 _aZheng, Min
700 1 _aZeng, Fan-Dian
700 1 _aGuo, Lian-Jun
773 0 _tCellular and molecular neurobiology
_gvol. 28
_gno. 4
_gp. 613-27
856 4 0 _uhttps://doi.org/10.1007/s10571-007-9165-x
_zAvailable from publisher's website
999 _c17241337
_d17241337